Calderon, Rufo .

HRN: 07-60-00  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/05/2023
CLOXACILLIN 500MG (CAP)
11/05/2023
11/11/2023
PO
500mg
Q6
R/O Tetanus; Punctured Wound
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: